The tumor-infiltrating lymphocytes (TILs) in the central and peripheral regions of the tumors were analyzed separately using markers including CD20, CD3, CD68, CD8, CD4, CD163 and FOXP3. This evidence concerns the gene FOXP3 and neoplasm.